IBOTTA arrives at its August 5 earnings report carrying a 31% loss over the past month, 13% short interest, and a CEO who has been selling shares throughout the slide.
The most striking feature of the setup is the alignment between short sellers and insiders — both are leaning the same way. Short interest now covers nearly 13% of the free float, a level that ranks in the bottom 1st percentile of the ORTEX universe by short score rank, and the ORTEX short score has held above 82 for every session this month. That is a persistently high reading, signalling that this is not a speculative short position but an entrenched one. Bryan Leach — Founder, Chairman and CEO — sold shares on at least six occasions between July 6 and July 21, while the Clark Jermoluk Founders Fund offloaded 500,000 shares on July 6 alone, a transaction worth $15 million. Net insider selling over the past 90 days totals roughly $17.9 million. When the person who built the company is selling into a 31% drawdown, it sharpens the question the print needs to answer.
Options positioning reinforces the cautious tone, though without the extreme defensiveness that would signal real panic. The put/call ratio has climbed to 0.24, nearly two standard deviations above its 20-day average of 0.20 — elevated relative to recent norms, but still near the low end of its 52-week range. Borrow conditions are not particularly tight: availability runs at 110%, meaning there are roughly as many shares available to lend as there are currently borrowed, and cost to borrow is a low 0.92%. Short sellers face no material squeeze pressure from the lending market going into the release.
The analyst community is fragmented, and the most recent institutional move skewed bearish. Goldman Sachs lowered its target to $28 on July 8, maintaining a Sell rating — a target the stock has now broken through, trading at $24.58. The broader consensus sits at a mean target near $33, but that figure blends bulls at Needham (target $45) with bears at Bank of America (Underperform, $22). The core disagreement is structural: bulls see Ibotta's pivot from a consumer app to a performance marketing network as a flywheel that will scale CPG advertiser relationships and attract new publishers; bears point to flat revenue growth projections for 2026 versus prior expectations of 19% growth, a salesforce reorganisation that reportedly dragged revenue down 16% on affected accounts, and persistent difficulty signing new publisher partners. The stock's trailing P/E has compressed sharply — down more than seven points over the past month to roughly 14.8x — reflecting how quickly the market has recalibrated expectations.
The print will therefore test whether Ibotta's publisher network is genuinely growing, and whether the salesforce restructuring is behind it or still weighing on results — the two metrics that separate the bull and bear cases entirely.
See the live data behind this article on ORTEX.
Open IBTA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
